DEFENERGY app for Patients with Myalgic Encephalomyelitis, Fibromyalgia, and Persistent COVID

Sly Saint

Senior Member (Voting Rights)
DEFENERGY: Empowering Patients with Myalgic Encephalomyelitis, Fibromyalgia, and Persistent COVID – Join the Community and Track Your Symptoms

With the goal of “uniting these patients, helping to create community and find a way to help advance research”, Manuel Ruiz Pablosresearcher and patient with ME or chronic fatigue syndrome (CFS), together with his team, are developing DEFENERGY, a application which allows the patient record all your symptoms to monitor the status of your illness, generating reports that prove its evolution to the medical staff.
But the ambition of the team that created DEFENERGY goes further. “The objective is not only to stay with these three diseases, but to get a diagnosis and a solution for them and add new diseases for which medicine has not found an explanation, and that research advances to give them a treatment and help them be recognized in the Spanish health system,” say the creators of the app.

https://www.archyde.com/defenergy-e...d-join-the-community-and-track-your-symptoms/

@Aroa
 
Last edited by a moderator:
I'm not clear whether this is a national or international project, and if national, which country.

I am very much in favour of such projects if well done, but a bit concerned about duplication of effort with several people developing similar apps, all with different diagnostic, symptom and activity tracking strategies. It gets a bit confusing as a patient deciding which one to try. I hope there is some coordination between developers, leading researchers and leading ME/CFS patient organisations.
 
I'm not clear whether this is a national or international project, and if national, which country.

I am very much in favour of such projects if well done, but a bit concerned about duplication of effort with several people developing similar apps, all with different diagnostic, symptom and activity tracking strategies. It gets a bit confusing as a patient deciding which one to try. I hope there is some coordination between developers, leading researchers and leading ME/CFS patient organisations.
Projects like this usually work out when data can be shared across teams and organizations. But health data is never shared, so all we end up with is multiple siloes. I used Visible for a few months, then gave up because, really, what's the point?

We need a revolution in how health data is used, but it's going to have to be far more fundamental, likely driven by AI. Otherwise things just get stuck by human obstacles.
 
Back
Top Bottom